Yu Shuai-Shuai, Du Ji-Mei, Tang Zhi-De, He Zhi-Feng
Department of Biology, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China.
Department of Cardiothoracic Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China.
Mol Med Rep. 2017 Apr;15(4):1832-1836. doi: 10.3892/mmr.2017.6216. Epub 2017 Feb 17.
Mutations in mitochondrial (mt)transfer (t)RNA (mt‑tRNA) have been reported to serve important roles in hypertension. To determine the underlying molecular mechanisms of mt‑tRNA mutations in hypertension, the present study screened for mt‑tRNA mutations in a Chinese family with a high incidence of essential hypertension. Sequence analysis of the mt‑tRNA genes in this family revealed the presence of an A4401G mutation in the glycine‑and methionine‑tRNA genes, and a G5821A mutation in the cysteine‑tRNA (tRNACys) gene. The G5821A mutation was located at a position conserved in various species, and disrupted G6‑C67 base‑pairing. It was hypothesized that the G5821A mutation may decrease the baseline expression levels of tRNACys, and consequently result in failure of tRNA metabolism. The A4401G mutation was reported to cause the mitochondrial dysfunction responsible for hypertension. Thus, the combination of G5821A and A4401G mutations may contribute to the high incidence of hypertension in this family. Mt‑tRNA mutations may serve as potential biomarkers for hypertension.
据报道,线粒体(mt)转运(t)RNA(mt-tRNA)突变在高血压中起重要作用。为了确定高血压中mt-tRNA突变的潜在分子机制,本研究在一个原发性高血压发病率高的中国家族中筛查mt-tRNA突变。对该家族中mt-tRNA基因的序列分析显示,甘氨酸和甲硫氨酸tRNA基因存在A4401G突变,半胱氨酸tRNA(tRNACys)基因存在G5821A突变。G5821A突变位于不同物种中保守的位置,破坏了G6-C67碱基对。据推测,G5821A突变可能会降低tRNACys的基线表达水平,从而导致tRNA代谢失败。据报道,A4401G突变会导致导致高血压的线粒体功能障碍。因此,G5821A和A4401G突变的组合可能是该家族高血压高发的原因。Mt-tRNA突变可能是高血压的潜在生物标志物。